Navigation Links
Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
Date:6/2/2008

rence in this press release.

Contacts:

Tim Warner (650) 283-4915 or twarner@nektar.com

Stephan Herrera (415) 488-7699 or sherrera@nektar.com

Jennifer Ruddock (650) 631-4954 or jruddock@nektar.com

References and Glossary

1 Simon, Richard, "Optimal Two-Stage Designs for Phase II Clinical

Trials," Controlled Clinical Trials 10:1-10 (1989)

2 E. Van Cutsem, I. Lang, G. D'haens, V. Moiseyenko, J. Zaluski, G.

Folprecht, S. Tejpar, O. Kisker, C. Stroh, P. Rougier, "KRAS status and

efficacy in the first-line treatment of patients with metastatic

colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab:

The CRYSTAL experience", J Clin Oncol 26: 2008 (May 20 suppl; abstr 2).


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 A new ... manage the clinical review of specialty pharmaceuticals has ... of drugs reviewed while reducing costs. ,, AIM, ... company with health plan clients representing over 35 ... Inc. (NYSE: WLP ), adapted the ...
(Date:12/16/2009)... 16 Hospira, Inc. (NYSE: HSP ... company, today announced that it will host a conference ... and projections for 2010 on Thursday, Feb. 4, 2010, ... release its fourth-quarter and full-year 2009 results earlier that ... conference call. ,, A live webcast of the conference ...
(Date:12/16/2009)... AVAX Technologies, Inc. (Pink Sheets: AVXT) ... recently closed a bridge loan financing (the "2009 ... Purchase Agreement (the "Agreement") with Firebird Global Master ... Company sold a convertible promissory note, due June ... US$1,400,000, and issued a warrant to purchase an ...
Breaking Medicine Technology:American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4University of Houston diesel testing center teams with state transportation agency to cut emissions 8884 1University of Houston diesel testing center teams with state transportation agency to cut emissions 8884 2University of Houston diesel testing center teams with state transportation agency to cut emissions 8884 3Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 1Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 2Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 3Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 4New Swine Flu Strain Found in Brazil 3A Report 49266 1New Swine Flu Strain Found in Brazil 3A Report 49266 2New Swine Flu Strain Found in Brazil 3A Report 49266 3New Swine Flu Strain Found in Brazil 3A Report 49266 4New Swine Flu Strain Found in Brazil 3A Report 49266 5New Swine Flu Strain Found in Brazil 3A Report 49266 6New Swine Flu Strain Found in Brazil 3A Report 49266 7New Swine Flu Strain Found in Brazil 3A Report 49266 8New Swine Flu Strain Found in Brazil 3A Report 49266 9New Swine Flu Strain Found in Brazil 3A Report 49266 10New Swine Flu Strain Found in Brazil 3A Report 49266 11New Swine Flu Strain Found in Brazil 3A Report 49266 12
... no evidence of the development of viral,resistance to ... C patients --, PRINCETON, N.J., Feb. 6 ... R7128 monotherapy resistance profile at,the EASL-AASLD-APASL-ALEH-IASL Conference on ... being held in Paris, France from February,14-16, 2008. ...
... -- Lotus Pharmaceuticals,Inc. (OTC Bulletin Board: LTUS) ... the People,s Republic of China ("PRC"), today,announced ... the development of,isosorbide mononitrate sustained release tablet, ... treatment of angina., Based on extensive ...
Other Medicine Technology:Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile 2Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile 3Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets 2Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets 3
(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a ... blood transfusion industry, today announced that Paul D. Mintz, ... new independent director, effective January 1, 2010. ,, ... transfusion medicine for more than 30 years. He is ... University of Virginia School of Medicine. He also serves ...
(Date:12/16/2009)... The most widely used human embryonic stem cell ... justice questions that must be addressed to ensure that ... according to a University of Michigan research team. ,, ... U-M team analyzed 47 embryonic stem cell lines, including ... researchers. The scientists determined the genetic ancestry of each ...
(Date:12/16/2009)... increase susceptibility to disease , , WEDNESDAY, Dec. 16 ... susceptibility to leprosy have been identified by scientists ... analyzed more than 10,000 DNA samples from leprosy ... discovery highlights the important role that the innate ... , "Though leprosy is not common, the discoveries ...
(Date:12/16/2009)... researchers at work on a malaria elimination study in ... of the disease using cell phone records. , The ... how often residents of Zanzibar travel and where they ... the coast of Tanzania in East Africa, Zanzibar has ... the study as part of deliberations on whether to ...
(Date:12/16/2009)... In animals, they cut bleeding time in half, but use ... (HealthDay News) -- Hoping to improve on nature, researchers have ... platelets, to be used in trauma or other cases where ... a core, with material that is used in degradable stitches, ... professor of biomedical engineering at Case Western Reserve University, and ...
Breaking Medicine News(10 mins):Health News:Immucor Appoints New Board Director 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:Leprosy Genes Identified 2Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3
... Americans live close to some type of emergency room, as ... hour away from the type of hospital that,s most prepared ... to a new University of Pennsylvania School of Medicine study ... Since little is known about which U.S. hospitals are best ...
... than 800 children received free basic dental services as ... dentists at 57 Heartland Dental Care practices across the ... worth of dentistry (including cleanings, X-rays, exams and more) ... see the dentist on a routine basis for basic ...
... a network of federally qualified community health centers, received ... (the American Recovery and Reinvestment Act) to provide primary ... President and CEO of Urban Health Plan said, "We ... the federal government. The funding is important to all ...
... N.J., March 17 Innophos Holdings, Inc. (Nasdaq: ... Directors has declared a dividend of $0.17 per share of ... 2009 to stockholders of record as of the close of ... Inc. , Innophos Holdings, Inc., the parent company of ...
... Specific Guidance to Maximize Appropriate Aspirin Use -MORRISTOWN, N.J., ... (USPSTF) today strongly recommends that patients and clinicians consider ... and stroke, while considering benefits and risks. These ... of Internal Medicine , build on the Task Force,s ...
... This release is available in French . ... infertility could be closer to reality, thanks to a ... Maisonneuve-Rosemont Hospital Research Centre. According to a study published ... researchers have become the first to clone, produce and ...
Other Medicine News:Health News:1 in 4 Americans lacks timely access to optimal care during time-sensitive medical emergencies 2Health News:1 in 4 Americans lacks timely access to optimal care during time-sensitive medical emergencies 3Health News:Heartland Dental Care Serves More Than 800 Children in Honor of National Give Kids A Smile(R) 2Health News:Urban Health Plan Receives $1.3M from Economic Stimulus Package to Increase Health Care Access in Corona, Queens 2Health News:Innophos Holdings, Inc. Declares Quarterly Dividend 2Health News:U.S. Preventive Services Task Force Encourages Broader Aspirin Use to Prevent Heart Attack and Stroke 2Health News:U.S. Preventive Services Task Force Encourages Broader Aspirin Use to Prevent Heart Attack and Stroke 3Health News:U.S. Preventive Services Task Force Encourages Broader Aspirin Use to Prevent Heart Attack and Stroke 4Health News:Researchers clone key sperm-binding proteins 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: